Phase I/II Radiation Dose-Escalation Trial of Intensity Modulated Radiotherapy (IMRT) with Concurrent Fixed Dose-Rate Gemcitabine (FDR-G) for Unresectable Pancreatic Cancer

被引：4
|
作者：
Ben-Josef, E. [1 ]
Schipper, M. [1 ]
Francis, I. [1 ]
Khan, G. [1 ]
Hadley, S. [1 ]
Lawrence, T. [1 ]
Simeone, D. [1 ]
Abrams, R. [2 ]
Sonnenday, C. [1 ]
Zalupski, M. [1 ]
机构：
[1] Univ Michigan, Med Ctr, Ann Arbor, MI USA
[2] Rush Univ, Med Ctr, Chicago, IL 60612 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2011年 / 81卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2011.06.263
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S127 / S128
页数：2
相关论文
共 50 条
  • [21] Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic cancer
    J. Feliu
    P. Borrega
    A. León
    L. López-Gómez
    M. López
    J. Castro
    C. Belda-Iniesta
    J. Barriuso
    V. Martínez
    M. González-Barón
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 215 - 221
  • [22] Intensity modulated radiotherapy in locally advanced thyroid cancer: Outcomes of a sequential phase I dose-escalation study
    Rooney, K. P.
    Miah, A. B.
    Bhide, S. A.
    Guerrero-Urbano, M. T.
    Sharabiani, M. T.
    Newbold, K. L.
    Grove, L.
    Harrington, K. J.
    Nutting, C. M.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 (01) : 43 - 48
  • [23] A phase I radiation dose-escalation study to determine the maximal dose of radiotherapy in combination with weekly gemcitabine in patients with locally advanced pancreatic adenocarcinoma
    Tom Budiharto
    Karin Haustermans
    Eric Van Cutsem
    Werner Van Steenbergen
    Baki Topal
    Raymond Aerts
    Nadine Ectors
    Didier Bielen
    Dirk Vanbeckevoort
    Laurence Goethals
    Chris Verslype
    Radiation Oncology, 3
  • [24] A phase I radiation dose-escalation study to determine the maximal dose of radiotherapy in combination with weekly Gemcitabine in patients with locally advanced pancreatic adenocarcinoma
    Budiharto, T
    Goethals, L
    Verslype, C
    Bielen, D
    Van Stenbergen, W
    Aerts, R
    Topal, B
    Van Cutsem, E
    Haustermans, K
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S273 - S273
  • [25] A phase I radiation dose-escalation study to determine the maximal dose of radiotherapy in combination with weekly gemcitabine in patients with locally advanced pancreatic adenocarcinoma
    Budiharto, Tom
    Haustermans, Karin
    Van Cutsem, Eric
    Van Steenbergen, Werner
    Topal, Baki
    Aerts, Raymond
    Ectors, Nadine
    Bielen, Didier
    Vanbeckevoort, Dirk
    Goethals, Laurence
    Verslype, Chris
    RADIATION ONCOLOGY, 2008, 3 (1)
  • [26] A phase I trial of fixed-dose-rate (FDR) gemcitabine and irinotecan combination in patients with advanced pancreatic and biliary cancer.
    Sun, W
    Theobald, ME
    Hershock, D
    Haller, DG
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 341S - 341S
  • [27] A Phase I Dose-Escalation Study of Lenalidomide in Combination with Gemcitabine in Patients with Advanced Pancreatic Cancer
    Ullenhag, Gustav J.
    Rossmann, Eva
    Liljefors, Maria
    PLOS ONE, 2015, 10 (04):
  • [28] Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial
    Ippolito, Edy
    Cellini, Numa
    Digesu, Cinzia
    Cilla, Savino
    Mantini, Giovanna
    Balducci, Mario
    Di Lallo, Alessandra
    Deodato, Francesco
    Macchia, Gabriella
    Massaccesi, Mariangela
    Mattiucci, Gian Carlo
    Tagliaferri, Luca
    Piermattei, Angelo
    Cuscuna, Daniele
    Morganti, Alessio G.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2013, 31 (01) : 87 - 92
  • [29] A phase II trial of full-dose gemcitabine with concurrent radiation therapy in patients with resectable or unresectable non-metastatic pancreatic cancer
    Small, W.
    Talamonti, M.
    Normolle, D.
    Freedman, G.
    Berlin, J.
    Kinsella, T.
    Philip, P.
    Zalupski, M.
    Mulcahy, M.
    Meropol, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S172 - S173
  • [30] Fixed dose rate infusion of gemcitabine with oral doxifluridine and leucovorin for advanced unresectable pancreatic cancer: A phase II study
    Kim, Hawk
    Park, Jae-Hoo
    Shin, Su Jin
    Kim, Mee-Ja
    Bang, Sung-Jo
    Park, Neung Hwa
    Nah, Yang Won
    Nam, Chang Woo
    Joo, Kwang Ro
    Min, Young Joo
    CHEMOTHERAPY, 2008, 54 (01) : 54 - 62
12345